Arrhythmias in Patients ≥80 Years of Age

Curtis et al. (Mon,) conducted a review in Arrhythmias. Age-specific management (drugs, catheter ablation, cardiac implantable electronic devices) was evaluated. Advancing age (≥80 years) is an independent risk factor for arrhythmias, but these patients are under-represented in clinical trials, leading to critical gaps in evidence for their management.

www.synapsesocial.com/papers/69f2ca21a9949f73c77cb9b9 — DOI: https://doi.org/10.1016/j.jacc.2018.03.019

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Cardiomyocyte apoptosis in hypertensive cardiomyopathy· 2003 · 142 citations
2. Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls· 1999 · 531 citations
3. Survival in octogenarians receiving implantable defibrillators· 2006 · 80 citations
4. Utilisation of cardiac pacemakers over a 20-year period: Results from a nationwide pacemaker registry· 2016 · 29 citations
5. Age‐Related Prognosis of Syncope Associated with a Preexcitation Syndrome